Kardex (KARN) Investor update summary
Event summary combining transcript, slides, and related documents.
Investor update summary
9 Jun, 2026Strategic growth initiative and investments
Launched a strategic growth initiative in late 2024, focusing on sales, marketing, IT, and R&D investments to target EUR 1.5 billion revenues by 2029–2031.
Aims for annual revenue growth of 10–14% and an EBIT margin of 10–14% in the mid-term.
Investments are intended to capture a larger share of the expanding automated intralogistics market.
Segment performance and financial outlook
Standardized Systems segment is performing as planned, while Automated Products segment saw slower growth since H2 2025.
Bookings in Automated Products have been increasing since March 2026.
Elevated costs and lower Automated Products volume will reduce H1 2026 EBIT to about 60% of the prior year period.
Full-year 2026 EBIT margin expected at 8–10%, below the original target, despite anticipated stronger H2 2026.
Full-year 2026 order and revenue growth forecasted at 15–20%.
Industry drivers and future outlook
Reshoring, labor shortages, and automation are key industry growth drivers.
Increasing sales synergies across business units are expected to support further profitable growth.
Confident in achieving mid-term financial targets for 2029–2031.
Latest events from Kardex
- Record bookings and EBIT in 2025 support a strong growth outlook for 2026 despite lower net profit.KARN
H2 202512 Mar 2026 - Kardex targets EUR 1.5bn revenue by 2029–2031, driven by healthcare automation and innovation.KARN
Investor Day 20254 Nov 2025 - Bookings and revenues rose sharply, with strong segment growth and a positive outlook.KARN
H1 202531 Jul 2025 - Double-digit growth, high cash flow, and automation trends drive a strong outlook.KARN
H1 202413 Jun 2025 - Record 2024 results, higher dividend, and raised growth targets amid robust intralogistics demand.KARN
H2 20246 Jun 2025